Background. On the basis of a nationwide registration during a 5-year period (1999)(2000)(2001)(2002)(2003), the frequency and severity of hearing loss was investigated retrospectively in 343 consecutive Danish patients who survived pneumococcal meningitis, to identify important risk factors (including the pneumococcal serotype) for development of hearing loss.
incidence of hearing impairment as sequela of pneumococcal meningitis ranges from 7% to 36% of survivors [2] [3] [4] [5] . It has been suggested that the higher figure may be closer to the actual incidence, considering the difficulties in detecting hearing loss, even severe cases, in retrospective studies. Moreover, little is known about risk factors for hearing loss.
The incidence and serotype pattern of pneumococcal meningitis vary by geographic location [6] [7] [8] , and casefatality rates differ according to occurring serotype [9, 10] . However, to our knowledge, the correlation between serotype and postmeningitis hearing loss has not been addressed previously and may be of interest in relation to future treatment and vaccination strategies. This study represents a nationwide investigation of the frequency and severity of postmeningitis hearing loss in consecutive Danish patients with pneumococcal meningitis during a 5-year period (1999) (2000) (2001) (2002) (2003) .
METHODS

Identification of patients.
Pneumococcal meningitis is a notifiable disease in Denmark, and all cases are reported to the Department of Epidemiology, Statens Serum Institut. All pneumococcal isolates obtained from cerebrospinal fluid (CSF) and blood are sent to the National Reference Laboratory at the Streptococcus Unit, Statens Serum Institut, for serotyping (Quelling reaction using type-specific pneumococcal rabbit antisera [Pneumosera; Statens Serum Institut]) and confirmatory antibiotic susceptibility testing. If a case with a positive CSF culture result is not reported initially, a request is sent out to ensure proper reporting of the case. Thus, the study represents a nationwide collection of consecutive cases with pneumococcal meningitis during a 5-year period (1999) (2000) (2001) (2002) (2003) . Pneumococcal meningitis was defined as a CSF culture positive for S. pneumoniae or CSF biochemical evidence of meningitis (eg, presence of CSF pleocytosis, decreased CSF glucose level, and elevated CSF protein level) in conjunction with a blood culture positive for S. pneumoniae.
Data collection. Clinical and laboratory data were retrieved from notification forms as well as hospital discharge records. When appropriate, additional medical records (including laboratory findings at hospital admission) were also collected. Audiometric data (obtained after a meningitis episode) were retrieved from the relevant audiological hospital departments. To obtain audiometric data on patients who had not been referred primarily for formal hearing assessment after a disease, a request to take part in the study was mailed to these patients. After informed consent was given, an audiometry was performed by a local, private oto-rhino-laryngologist chosen by the patient, and the results mailed to the authors.
Our study of hearing loss after pneumococcal meningitis was comprised of 2 parts: (1) information on hearing loss, as evaluated by use of a short clinical bedside examination conducted by a nonspecialized physician before hospital discharge, obtained from the primary discharge records and medical records and (2) audiometric testing. All protocols were approved by the regional scientific ethics committee (record KA-20060023) and the Danish Data Protection Agency (record 2002-41-2278).
Audiometric testing. Before audiometric testing, all subjects had had an otoscopy performed to establish a patent ear canal. Standard pure-tone audiometry was performed from 0.25 to 8 kHz. The mean hearing thresholds obtained were compared to an age-and sex-matched normative data set. The normative data set consisted of an otologically unscreened population sample, divided into 7 age groups, each group further subdivided by sex and severity of ear disease (ie, better or worse ear) [11] . The pure-tone average (PTA) was calculated as the average of thresholds at 0.5, 1, 2, and 4 kHz, and the PTA hearing loss (DPTA) was calculated as the difference between the postmeningitic PTA and the PTA of the age-and sexmatched control data. Hearing, when tested by use of audiometry, was classified for each ear as follows: no hearing loss, mild hearing loss (у5 dB in 3 consecutive frequencies or у10 dB in 2 consecutive frequencies above the individually matched normative data set), severe hearing loss (DPTA, 30-70 dB), and profound hearing loss (DPTA, у70 dB). In addition, hearing loss was categorized as unilateral or bilateral.
Children who could not be assessed by use of standard audiometry because of their young age were assessed by use of play audiometry, behavioral audiometry (including a distraction test), visual reinforcement orientation audiometry, or an auditory brain-stem response or an otoacoustic emissions test was used. When these tests had been performed, we used a 20-dB hearing threshold as normal reference.
Statistical analysis. All data are presented as median values and interquartile ranges. Comparisons between groups were performed by use of the Fisher exact test for categorical data and the Mann-Whitney test for continuous data. The relative risk of hearing loss was calculated by use of univariate and multivariate logistic regression (SPSS, version 16.0; SPSS). Patients who experienced more than 1 episode of meningitis were excluded from logistic regression analysis. Only variables with more than 80% of value available and with a P value of less than .2 in the univariate analysis were tested in the multivariate analysis. A P value of less than .05 was considered to be statistically significant.
RESULTS
Identification of patients with meningitis.
A total of 506 consecutive episodes of pneumococcal meningitis involving 502 patients were identified during the period from January 1999 through December 2003. One patient had had 3 episodes of pneumococcal meningitis, and 2 patients had had 2 episodes. Each episode for these 3 patients was due to a different serotype. Of the 502 included patients, 107 (21%) died of the primary disease. Of the remaining 395 patients, 305 (77%) had medical records and discharge card information on hearing.
From the end of the inclusion period in 2003 to the end of data collection in 2009, 39 of the 395 primary survivors had died of other causes, 7 had emigrated or were residents of countries other than Denmark, and 6 were unable to be assessed by use of an audiometry because of health-related issues. Of the remaining 343 patients, 171 (50%) had an audiometry performed in relation to the primary disease, and 69 (20%) had an audiometry performed in relation to this study (see below). Thus, audiometric data were available for 240 (70%) of 343 possible cases. The median time between onset of disease and audiometric testing was 12 months (25th-75th percentiles: 3-60 months; range, 0-106 months). Four patients had audiometry performed within the first week after hospital admis- ). N p 505 The hearing loss was determined by audiometric testing. Adult patients had a higher mortality and a higher occurrence of hearing loss, compared with pediatric patients ( ). P ! .001 sion, whereas the majority of audiometric assessments (87%) were performed 2 months or more after hospital admission.
Comparison of bedside hearing evaluation and audiometric testing. The incidence of hearing loss was significantly higher for patients tested by use of audiometry than for patients with hearing data obtained from medical records (54% [129/240] vs 27% [81/305];
). For 192 patients, hearing data ex-P ! .001 isted both from medical records and from audiometry proper. Fifty patients were evaluated as having no hearing loss at hospital discharge; however, an abnormal audiometric test result was demonstrated subsequently. In addition, audiometric testing could not confirm the suspicion of hearing loss for 8 adult patients. Six of these 8 patients had an ear focus and were discharged after a median of 12 days (range, 10-27 day), so the initial hearing loss could potentially be of conductive causes and may have improved before audiometric testing. The sensitivity, specificity, and positive and negative predictive values of medical records regarding hearing loss were respectively 51%, 91%, 87%, and 62% for all patients (38%, 100%, 100%, and 81% for children and 54%, 77%, 85%, and 42% for adults). Therefore, all hearing data are from audiometric testing only. Occurrence and severity of hearing loss. A significantly higher proportion of patients with posthospitalization audiometric data had hearing loss, compared with patients examined after receiving the mailed request in relation to this study (102/ 171 [60%] vs 27/69 [39%];
). Of the 240 patients tested P p .004 by use of audiometry, 105 (44%) had hearing loss in the better ear. Of these patients, 81 (77%) were classified as having mild hearing loss, 8 (8%) were classified as having severe hearing loss, and 16 (15%) were classified as having profound hearing loss. Of the 123 patients (51%) with hearing loss in the worse ear, 69 (56%) were classified as having mild hearing loss, 22 (18%) were classified as having severe hearing loss, and 32 (26%) were classified as having profound hearing loss. Of the 240 patients tested by use of audiometry, 109 (54%) were found to have at least unilateral mild hearing loss, whereas there were 56 patients (23%) who had severe to profound hearing loss in at least 1 ear, 32 patients (13%) who had profound hearing loss unilaterally or bilaterally, and 16 patients (7%) who had profound hearing loss bilaterally.
The mean pure-tone thresholds for the better ear, the worse ear, and both ears are shown in Figure 1 . Patients with mild to profound hearing loss were found to have an average hearing loss (DPTA) of 27.5 dB (95% confidence interval [CI], 22.4- ). The hearing loss was determined by audiometric testing. The occurrence of hearing loss was related to bacterial serotype, with serotype 6B associated 505 with a lower incidence of hearing loss, compared with serotype 12F, which was the most frequently occurring serotype ( ). The unlabeled bar at P ! .05 the top indicates cases with no data on serotype.
33.5 dB) in the better ear, 38.6 dB (95% CI, 33.0-44.3 dB) in the worse ear, and 33.5 dB (95% CI, 29.6-37.4 dB) when calculated for both ears.
Risk factors for hearing loss. Data on patient age in relation to survival and hearing outcome are presented in Figure 2 . The occurrence of pneumococcal meningitis was highest for patients young than 3 ), whereas predisposing conditions or a potential pri-P p .04 mary focus of infection was of no importance for a development of hearing loss ( ). P 1 .05 Clinical features (such as fever, back rigidity, decreased consciousness, and convulsion) were not statistically significantly associated with the occurrence of hearing loss ( ). In P 1 .05 contrast, the severity of meningitis, as reflected by the need for assisted ventilation or signs of septic shock (eg, hypotension with the need for blood pressure support and/or disseminated intravascular coagulation), was significantly related to the development of hearing loss (69% [ ) ( Table 1) . P p .01 Compared with patients with normal hearing, patients with hearing loss had a lower CSF glucose level and a higher CSF protein level ( ), whereas the CSF white blood cell (WBC) P ! .05 count was not associated with hearing loss ( ). WBC P p .20 counts were not statistically significantly associated with hearing loss ( ), whereas patients with hearing loss had signifi-P 1 .05 cantly lower serum sodium levels than did patients without hearing loss.
Hearing loss and pneumococcal serotype. Serotype distribution in relation to survival and hearing outcome are presented in Figure 3 . Of 502 isolates tested, 10 (2%) were resistant to penicillin (minimum inhibitory concentration, 11 mg/L). The occurrence of a serotype was related to the patient's age, because the 4 most prevalent serotypes (7F, 6B, 12F, and 3) occurred, respectively, in 29% (12/42 episodes), 63% (25/40 episodes), 5% (2/39), and 3% (1/32 episodes) of children !3 years of age. Fourteen cases had received pneumococcal vaccination prior to the meningitis episode (7 cases were vaccine failures). Table 2 shows the serotype-specific proportion of patients with hearing loss for the 9 most frequent serotypes and the related odds ratio (OR) estimates in comparison with the most frequent serotype (serotype 12F). Serotype 6B and serotype 14 were associated with a significantly lower risk of hearing loss, compared with serotype 12F, in the unadjusted OR analysis ( ). P 1 .05
DISCUSSION
The present, nationwide study of 502 consecutive episodes of pneumococcal meningitis in Denmark over a 5-year period (1999) (2000) (2001) (2002) (2003) showed that, among 240 survivors who were tested by use of audiometry, the overall rate of hearing loss was 54% (69% of adults and 31% of children): 23% had severe to profound hearing loss in at least 1 ear, and 13% had profound hearing loss unilaterally or bilaterally. To our knowledge, this is the largest audiometric study of hearing loss after pneumococcal meningitis. The incidence of hearing loss among adult survivors was more than twice as high as reported in previous studies (15%-26%) [3, 12, 13] , whereas previous studies in children showed variable hearing loss frequencies (7%-Downloaded from https://academic.oup.com/cid/article-abstract/51/8/917/332177 by guest on 07 January 2019 36%) [2, 4, 14, 15] . This discrepancy may be explained by differences in methods of hearing evaluation between studies, because audiometric testing was only performed for patients clinically suspected of hearing loss in most previous studies, whereas we intended to test all patients. Indeed, we found that 38% of patients, who were not suspected of hearing loss at clinical bedside evaluation before hospital discharge, had hearing loss when tested by audiometry. Thus, our results indicate that a rough, clinical bedside evaluation of hearing loss by a nonspecialized physician may be of limited value, and we suggest that postmeningitis audiometric testing should be performed in all cases.
The risk factors for hearing loss identified in the unadjusted univariate analysis were advanced age, presence of comorbidity, severity of meningitis (eg, the need for assisted ventilation or signs of septic shock), a low CSF glucose level, and a high CSF protein level, which confirm previous findings [4, 14] . Also, a low serum level of sodium was associated with a higher risk of hearing loss, whereas no association was found between hearing loss and WBC count in CSF and blood. In the multivariate analysis, age and sex were of significant importance.
Although controversial, corticosteroids have been recommended as adjunctive therapy for bacterial meningitis to reduce the risk of developing hearing loss [16] . In Denmark, some pediatric departments use corticosteroids routinely as adjunctive therapy, whereas corticosteroids for treatment of adults were recommended in 2003 [17] . Before 2003, corticosteroids were used only for adult patients with severe brain edema. Thus, hearing loss was significantly higher in adult patients treated with corticosteroids but was slightly lower in pediatric patients.
Our study showed that pneumococcal serotype was associated with hearing loss after meningitis, because cases of meningitis due to serotype 6B and serotype 14 were associated with a lower risk of hearing loss, compared with serotype 12F. This was also found when we adjusted for other significant risk factors in multivariate analysis. An association between serotypes and mortality has previously been demonstrated [9, 10] , which could result in an important selection bias for the identification of risk factors for the development of hearing loss; for example, risk for development of hearing loss could be underestimated in serotypes with a high mortality, because severity of the disease is associated with both mortality and hearing loss. However, serotypes 6B, 14, and 12F were associated with similar mortality rates in this study, as in previous studies [10] . Moreover, when we studied the relationship between serotypes and an unfavorable outcome (combination of hearing loss and mortality), no significant association was found (data not shown). Furthermore, serotypes not included in the 7-valent and the 13-valent resulted in higher risk for hearing loss than did vaccine serotypes, which is in conflict with a previous study of 86 children [18] . Thus, the pneumococcal serotype may be an important risk factor for the development of hearing loss.
Our study has some advantages over previous studies concerning this subject matter. Because meningitis is a notifiable disease with a centralized, national registration, we most likely identified all episodes during the period. Serotyping was performed in 93% of episodes. Thus, the study represents a large collection of unselected, consecutive cases. The large sample size allowed multivariate analysis, to identify risk factors for the development of hearing loss. Moreover, we compared postmeningitic hearing to normative data from an otologically unscreened population sample [11] . This method is likely to be more sensitive than previous study designs, considering the difficulties in detecting hearing loss in retrospective case series lacking predisease reference values.
Nevertheless, our study has some potential limitations. First, children younger than at least 5 years of age cannot participate in standard pure-tone audiometry. Thus, the detection and categorization of hearing loss is definitely more uncertain in the younger pediatric age group. Therefore, the incidence of hearing loss in these patients is probably underestimated, which may have introduced a bias in relation to the occurring, agerelated difference. Second, audiometric data could not be retrieved for a proportion of our cohort (30%), which may have resulted in a selection bias. Patients not responding to our letter requesting an audiometry by their local oto-rhino-laryngologist may be assumed not to have considerable hearing problems, which may have led to an overestimation of the occurrence of hearing loss overall. Finally, although most patients with hearing loss after meningitis have a permanent loss of hearing, improvement does occur in rare cases [19, 20] . In our study, 4 patients had audiometry performed within the first week after hospital admission, whereas the vast majority of audiometric assessments (87%) were performed 2 months or more after admission.
Hearing loss is common after pneumococcal meningitis, and audiometry should be performed on all patients. Important risk factors for hearing loss are advanced age, female sex, severity of meningitis, and the presence of a certain bacterial serotype.
